Cancer Epigenomics

Cancer epigenetics is the study of epigenetic modifications to the genome of cancer cells that do not involve a change in the nucleotide sequence. Epigenetic alterations are as important as genetic mutations behind the transition of a cell from normal to cancerous, and their manipulation holds great promise for cancer prevention, detection and therapy. In different types of cancer, a variety of epigenetic mechanisms can be perturbed, such as silencing of tumor suppressor genes and activation of oncogenes by altered CpG island methylation patterns, histone modifications and dysregulation of DNA binding proteins.

  • Cancer genomics
  • Epigenetic influence on genomic stability
  • Moleculatr underpinnings of therapeutic targets
  • Aberrant DNA methylation genes
  • Tumor heterogeneity

Related Conference of Cancer Epigenomics

June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 24-25, 2024

7th International Conference on Anti-Cancer Drugs

Vancouver, Canada

Cancer Epigenomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in